Cash from Operations (Annual) Chart

Historical Cash from Operations (Annual) Data

View and export this data back to 2019. Start Trial.
Date Value
December 31, 2025 -105.76M
December 31, 2024 -57.78M
December 31, 2023 -156.20M
December 31, 2022 -130.81M
Date Value
December 31, 2021 -148.16M
December 31, 2020 -53.20M
December 31, 2019 -103.86M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Annual) Range, Past 5 Years

View Cash from Operations (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Annual) Benchmarks

View Cash from Operations (Annual) Benchmarks
Start Trial
Astrana Health, Inc. 114.60M
Starling Oncology, Inc. -24.59M
Nakamoto, Inc. -23.51M
American Oncology Network, Inc. --
Tenet Healthcare Corp. 3.54B